Sign in

ABN AMRO Bank N.V. ABN.AS

Price 42.3 EUR
as of 2026-09-03
54/100
Constructive
Quality56
Growth20
Balance-sheet strength38
Valuation63
Momentum93
Income61

Composite 54/100; the shares have moved about 28% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 20/100 — a strong mark against it.

Case for

Momentum ranks 93/100 — a strong point in its favour. Valuation ranks 63/100 — a moderate point in its favour. Income ranks 61/100 — a slight point in its favour.

Case against

Growth ranks 20/100 — a strong mark against it. Balance-sheet strength ranks 38/100 — a moderate mark against it.

What the company does ABN AMRO Bank N.V. (ABN.AS) is a Dutch diversified bank offering retail, private, and corporate banking services across the Netherlands, Europe, and internationally. Its segments include Personal & Business Banking, Wealth Management, and Corporate Banking, providing mortgages, investment products, insurance, and digital banking solutions.

Key financials ABN AMRO reports ROE of 8% and net margins of 27%, with revenue and EPS growth of 4% and 16%, respectively. The bank yields a 3% dividend with a 51% payout ratio. Forward P/E is 13.2x (PEG 1.05), and valuation metrics include P/B of 1.12x.

Stock health The stock shows strong momentum: +25% over 3/6 months and +59% over 12 months, though down 5% from its 52-week high. Sideravia scores Valuation at 74% and Momentum at 81%, while Quality is average at 59%. RSI(14) stands at 47.

Price vs fair value The stock trades at a PREMIUM of 13.50% to our fair-value estimate of 32.00 and a discount of 7.77% to the 12-month target of 39.85. - Trading above fair value amid strong 12-month momentum (Sideravia). - Analysts’ 39.85 target implies 8% upside from current levels (analyst count 19). - Recent earnings beats in European banking may support sentiment (Standard Chartered Q2 results surpass estimates, Zacks).

Looking forward Forward earnings growth and valuation multiples suggest moderate upside potential, but the premium to fair value and high momentum may limit near-term gains. Dividend yield and improving profitability remain supportive tailwinds.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.